Thank you for reading this version of Macula Matters, MDFA’s newsletter for healthcare professionals.
We welcome Mr Graeme Head AO as the new Chairman of the MDFA Board.
Participate in new intervention designed to improve glaucoma and diabetic eye care.
The US FDA recently approved two treatments: Susvimo® and Vabysmo®.
Volunteers with AMD sought to build a new computerised instrument.
Read the latest from CERA researchers Dr Zhichao Wu, Himeesh Kumar and Prof Robyn Guymer.
The latest on our efforts to ensure accessible IVI for Australian patients.
MDFA’s summer 2021 edition of Vision Voice newsletter is out now!
In the latest Macula Matters, we cover CPD webinars, updates on the latest macular disease research, and a survey to help us work together to support patients.